Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.840
-0.110 (-2.78%)
At close: Sep 18, 2026, 4:00 PM EDT
3.830
-0.010 (-0.26%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Rezolute Employees
Rezolute had 68 employees as of March 31, 2026. The number of employees did not change compared to the same quarter last year.
Employees
68
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,198,309
Market Cap
401.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 68 | 0 | - |
| Dec 31, 2025 | 75 | 11 | 17.19% |
| Sep 30, 2025 | 75 | 57 | 316.67% |
| Jun 30, 2025 | 71 | 12 | 20.34% |
| Mar 31, 2025 | 68 | 13 | 23.64% |
| Dec 31, 2024 | 64 | 7 | 12.28% |
| Sep 30, 2024 | 18 | -32 | -64.00% |
| Jun 30, 2024 | 59 | 8 | 15.69% |
| Mar 31, 2024 | 55 | 8 | 17.02% |
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Sep 30, 2023 | 50 | 8 | 19.05% |
| Jun 30, 2023 | 51 | 9 | 21.43% |
| Mar 31, 2023 | 47 | 5 | 11.90% |
| Dec 31, 2022 | 48 | - | - |
| Jun 30, 2022 | 42 | 16 | 61.54% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsRZLT News
- 10 days ago - Rezolute provides update on FDA review of sunRIZE study - TheFly
- 10 days ago - Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism - GlobeNewsWire
- 17 days ago - Rezolute to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Rezolute to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 2 months ago - Rezolute Slides: Corporate presentation - Filings
- 3 months ago - Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society - GlobeNewsWire
- 3 months ago - Rezolute price target raised to $11, named a Best Idea at Guggenheim - TheFly
- 3 months ago - Rezolute Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts